MaltSci 麦伴科研

Appearance

Popular Reports / Public Health

This report is written by MaltSci based on the latest literature and research findings

What are the impacts of emerging infectious diseases? ​

Abstract ​

Emerging infectious diseases (EIDs) pose a significant challenge to global health, with their potential to cause widespread morbidity and mortality. EIDs include both newly identified pathogens and previously known pathogens that have evolved or spread to new populations. Factors such as environmental changes, globalization, urbanization, and human behaviors contribute to the emergence of these diseases, which can overwhelm health systems, strain economic resources, and exacerbate social inequalities, particularly in low- and middle-income countries (LMICs). This review provides a comprehensive overview of EIDs, examining their definition, classification, contributing factors, health impacts, economic and social consequences, and strategies for mitigation and preparedness. Key findings indicate that EIDs lead to increased morbidity and mortality rates, disrupt healthcare systems, and impose significant economic burdens on societies. Furthermore, the social implications of EIDs are profound, as they can exacerbate existing inequalities and disrupt community cohesion. Effective strategies for addressing EIDs include enhancing surveillance, implementing public health interventions, promoting vaccination, and fostering global collaboration. In conclusion, understanding the multifaceted impacts of EIDs is crucial for developing comprehensive strategies to mitigate their effects and improve public health outcomes.

Outline ​

This report will discuss the following questions.

  • 1 Introduction
  • 2 Definition and Classification of Emerging Infectious Diseases
    • 2.1 Overview of Emerging Infectious Diseases
    • 2.2 Classification of EIDs: Newly Identified vs. Re-emerging Diseases
  • 3 Factors Contributing to the Emergence of Infectious Diseases
    • 3.1 Environmental Changes and Climate Impact
    • 3.2 Globalization and Travel
    • 3.3 Urbanization and Population Density
    • 3.4 Human Behavior and Zoonotic Spillover
  • 4 Health Impacts of Emerging Infectious Diseases
    • 4.1 Burden on Health Systems
    • 4.2 Morbidity and Mortality Rates
    • 4.3 Mental Health Consequences
  • 5 Economic and Social Impacts
    • 5.1 Economic Consequences of EIDs
    • 5.2 Impact on Workforce and Productivity
    • 5.3 Social Disruption and Inequality
  • 6 Strategies for Mitigation and Preparedness
    • 6.1 Surveillance and Early Detection
    • 6.2 Public Health Interventions
    • 6.3 Role of Vaccination and Treatment
    • 6.4 Importance of Global Collaboration
  • 7 Conclusion

1 Introduction ​

Emerging infectious diseases (EIDs) represent a formidable challenge to global health, with their potential to inflict widespread morbidity and mortality. These diseases encompass both newly identified pathogens and previously known pathogens that have evolved or spread to new populations, driven by an intricate interplay of factors such as environmental changes, globalization, urbanization, and human behaviors. The emergence of EIDs has significant implications not only for public health but also for economic stability and social dynamics, necessitating a comprehensive understanding of their impacts. The importance of addressing EIDs is underscored by their capacity to disrupt health systems, strain economic resources, and exacerbate social inequalities, particularly in low- and middle-income countries (LMICs) with fragile health infrastructures[1][2].

The historical context of EIDs highlights a persistent pattern of infectious disease emergence, often catalyzed by changes in human demographics, land use, and climate[3][4]. For instance, the COVID-19 pandemic has starkly illustrated the vulnerabilities of global health systems and the urgent need for enhanced surveillance and preparedness mechanisms[2]. In recent decades, notable outbreaks of diseases such as SARS, Ebola, and Zika have reinforced the notion that EIDs can have devastating effects on public health and global stability[5][6]. The World Health Organization has emphasized that the interconnectedness of our modern world increases the likelihood of rapid disease spread, necessitating international cooperation and coordination to mitigate these threats[7].

The significance of studying EIDs lies in their multifaceted impacts, which extend beyond health to include economic and social dimensions. EIDs can overwhelm health systems, leading to increased morbidity and mortality rates, while also imposing significant economic burdens on societies[2][8]. Furthermore, the social implications of EIDs are profound, as they can exacerbate existing inequalities and disrupt community cohesion[9]. Understanding these diverse impacts requires a multidisciplinary approach that incorporates epidemiology, microbiology, public health, and socio-economic analysis[10].

This review is structured to provide a comprehensive overview of the impacts of emerging infectious diseases, organized as follows:

  1. Definition and Classification of Emerging Infectious Diseases: This section will provide an overview of EIDs, distinguishing between newly identified and re-emerging diseases.

  2. Factors Contributing to the Emergence of Infectious Diseases: We will explore various drivers of EID emergence, including environmental changes, globalization, urbanization, and human behavior.

  3. Health Impacts of Emerging Infectious Diseases: This section will assess the burden of EIDs on health systems, examining morbidity and mortality rates, as well as mental health consequences.

  4. Economic and Social Impacts: We will analyze the economic consequences of EIDs, their effects on workforce productivity, and the broader social disruptions they can cause.

  5. Strategies for Mitigation and Preparedness: This section will highlight effective strategies for surveillance, public health interventions, vaccination, and the importance of global collaboration in addressing EIDs.

  6. Conclusion: Finally, we will summarize the key findings and discuss the implications for future research and policy-making in the context of EIDs.

By synthesizing current knowledge and highlighting key trends and case studies, this report aims to elucidate the challenges posed by EIDs and propose strategies for mitigating their impacts. The urgency of enhancing preparedness and response mechanisms, along with fostering international collaboration, cannot be overstated in the face of these complex health threats.

2 Definition and Classification of Emerging Infectious Diseases ​

2.1 Overview of Emerging Infectious Diseases ​

Emerging infectious diseases (EIDs) are defined as newly recognized infections or those that have significantly increased in incidence or geographic range. These diseases can arise from various pathogens, including bacteria, viruses, fungi, and parasites. The emergence of these infectious diseases poses significant public health challenges, affecting both developed and developing nations. The impacts of EIDs extend beyond health, influencing political, economic, social, and environmental domains, as well as inter-state relations.

The impact of EIDs on health is profound, as they can lead to increased morbidity and mortality rates, disrupt healthcare systems, and necessitate the reallocation of resources. For instance, the COVID-19 pandemic has underscored deficiencies in global health systems, emergency management, and disease surveillance, highlighting the urgent need for effective evaluation tools and the importance of international cooperation to address these health threats (Zhang et al. 2023) [2]. Moreover, the rapid spread of diseases such as SARS, Ebola, and Zika has shown how interconnected modern civilization is, with outbreaks often crossing borders and affecting multiple countries simultaneously (Chattu & Yaya 2020) [9].

EIDs also have significant socio-economic implications. The outbreaks can lead to economic instability, as seen during the COVID-19 pandemic, where public health emergencies have imposed substantial burdens on economies and social development (Zhang et al. 2023) [2]. Furthermore, in resource-poor settings, the consequences of EIDs are exacerbated by existing vulnerabilities in health systems, leading to dramatic social and economic consequences when outbreaks occur (Chattu & Yaya 2020) [9].

From a broader perspective, EIDs influence inter-state relations, as countries may need to collaborate on surveillance, control measures, and research to effectively manage these health threats. The emergence of infectious diseases often necessitates international and interdisciplinary partnerships to build appropriate infrastructure for detection and response (Cohen 1998) [3].

In summary, the impacts of emerging infectious diseases are multifaceted, affecting health, economy, society, and international relations. Addressing these challenges requires comprehensive strategies that encompass surveillance, research, and international cooperation to enhance resilience against future outbreaks.

2.2 Classification of EIDs: Newly Identified vs. Re-emerging Diseases ​

Emerging infectious diseases (EIDs) are defined as diseases that have appeared recently or that have recently increased in their frequency, geographical distribution, or both. They constitute significant health problems and are becoming of major importance globally. According to various studies, up to 75% of EIDs and re-emerging infectious diseases (REIDs) have zoonotic origins, indicating a strong connection between animal health and human health [11].

The classification of EIDs can be divided into two primary categories: newly identified diseases and re-emerging diseases. Newly identified diseases refer to those that have recently been discovered or recognized, which may not have been previously known to science. On the other hand, re-emerging diseases are those that were previously under control but have since resurfaced, often due to changes in the environment, human behavior, or pathogen evolution [12].

The emergence of these diseases is driven by a combination of socio-economic, environmental, and ecological factors. Factors such as habitat destruction, climate change, and increased human-animal interactions contribute significantly to the emergence and spread of EIDs [13]. For instance, wars and natural disasters can exacerbate the emergence of infectious diseases by destroying health systems, displacing populations, and interrupting disease prevention programs [11].

The impact of EIDs is profound, affecting not only public health but also socio-economic stability and biodiversity. EIDs are recognized for their significant social, economic, and ecological costs, threatening human health, food security, wildlife conservation, and biodiversity [14]. The emergence of zoonotic diseases, which account for a majority of EIDs, poses a dual threat: they not only impact human health but also threaten wildlife populations and ecosystems [15].

In summary, EIDs can be classified into newly identified and re-emerging diseases, both of which pose significant challenges to global health. The interplay of environmental changes, human activities, and socio-economic factors is crucial in understanding the emergence and spread of these diseases, necessitating comprehensive surveillance and control measures to mitigate their impacts [16][17].

3 Factors Contributing to the Emergence of Infectious Diseases ​

3.1 Environmental Changes and Climate Impact ​

Emerging infectious diseases pose significant public health challenges, influenced by various factors, particularly environmental changes and climate impacts. The interplay between anthropogenic activities and infectious disease dynamics is complex, involving socioeconomic, ecological, and biological components.

Environmental changes, including habitat fragmentation, deforestation, urbanization, and climate change, have been identified as major contributors to the emergence and re-emergence of infectious diseases. For instance, a comprehensive literature review indicated that outbreaks of infectious diseases such as Chikungunya, dengue fever, and Zika are closely associated with climate events like El Niño, La Niña, heatwaves, and increased rainfall. These climatic variations alter the habitats and behaviors of vectors and pathogens, thereby influencing disease transmission dynamics[18].

A meta-analysis highlighted that biodiversity loss, chemical pollution, and climate change significantly correlate with increased disease-related endpoints. In contrast, urbanization appears to reduce certain disease endpoints. This analysis included data from 2,938 observations across various host-parasite combinations, indicating that while some environmental changes exacerbate disease risks, urbanization can have a mitigating effect[19].

Climate change specifically impacts the epidemiology of infectious diseases by modifying the survival and reproduction of pathogens and vectors. Rising temperatures and altered precipitation patterns can create more favorable conditions for disease transmission, expanding the geographic range of certain pathogens into areas previously free of such infections. For example, increasing global temperatures have been linked to the higher incidence of vector-borne diseases, including those affecting kidney health, where climate-associated factors contribute to the emergence of zoonotic, vector, and waterborne diseases[20].

Moreover, climate change also has implications for the social determinants of health, particularly in vulnerable populations. Those living in low- and middle-income countries are disproportionately affected, facing challenges such as limited access to healthcare and increased susceptibility to climate-related health risks[21]. The emergence of infectious diseases in these contexts is often compounded by factors such as mass migration, which disrupts health systems and exacerbates the spread of communicable diseases[22].

In summary, the impacts of emerging infectious diseases are closely tied to environmental changes and climate factors. These influences alter the ecological dynamics of pathogens and vectors, disrupt healthcare systems, and exacerbate health inequities, necessitating a multifaceted approach to disease management and public health strategies. Addressing these challenges requires integrated surveillance systems, effective outreach programs, and collaborative efforts across disciplines to mitigate the health impacts of climate change on infectious diseases[23][24].

3.2 Globalization and Travel ​

Emerging infectious diseases pose significant public health challenges globally, impacting both developed and developing nations. These diseases, which include new or previously unrecognized bacterial, viral, fungal, and parasitic infections, have emerged prominently over the past two decades. Factors contributing to this emergence include changes in human demographics and behavior, technological advancements, environmental alterations, and microbial adaptation. The consequences of these changes can be unpredictable and multifaceted, leading to a heightened vulnerability of populations to new health threats[3].

In particular, the rapid increase in population and urban migration has been associated with a notable shift in the epidemiology of infectious diseases. In regions like Djibouti, for example, diseases that were once controlled or unknown have re-emerged, significantly straining public health resources. Key infectious diseases affecting this area include malaria, AIDS, tuberculosis, dengue fever, and cholera, all of which have gained prominence due to socioeconomic factors such as increasing poverty and ecological changes[25].

Globalization and the increased frequency of international travel have further exacerbated the spread of infectious diseases. Air travel facilitates swift connections between distant locations, allowing pathogens to disseminate rapidly across borders. This has led to a surge in the frequency and reach of infectious disease epidemics, highlighting the need for robust surveillance and early-warning systems to detect and respond to these threats. Notably, public health responses have evolved to address the implications of air travel, with initiatives aimed at safeguarding global health, such as the implementation of sanitary regulations and travel advisories[[pmid:30049602][pmid:32288366]].

The impact of travel on infectious disease emergence is profound. Individuals traveling to regions with endemic diseases may be at increased risk due to their activities or may inadvertently act as vectors, introducing pathogens to new areas. Recent examples of diseases linked to travel include HIV, Legionnaire's disease, and cholera, underscoring the role of mobility in the emergence and reemergence of infectious diseases[26].

Moreover, societal and environmental factors, including climate change, urbanization, and alterations in land use, have been identified as critical elements influencing the emergence of infectious diseases. These factors not only facilitate the spread of pathogens but also contribute to the development of drug-resistant strains, complicating control efforts[4].

The increasing interconnectedness of populations through travel, combined with the aforementioned societal changes, necessitates a coordinated global response to effectively address the challenges posed by emerging infectious diseases. Building strong international partnerships and enhancing public health infrastructure are vital steps in preparing for and mitigating the impacts of these health threats[[pmid:21896363][pmid:19891855]].

In summary, the emergence of infectious diseases is influenced by a complex interplay of factors, including globalization and travel, which significantly impact public health systems worldwide. Addressing these challenges requires comprehensive strategies that encompass surveillance, prevention, and response mechanisms at both local and global levels.

3.3 Urbanization and Population Density ​

Emerging infectious diseases (EIDs) are significantly influenced by various factors, particularly urbanization and population density. The dynamics of urbanization create conditions that can either exacerbate or mitigate the spread of infectious diseases. The relationship between urbanization and EIDs is complex and multifaceted, as evidenced by multiple studies that highlight the effects of demographic changes, socioeconomic factors, and environmental modifications.

Urbanization is characterized by rapid population growth, economic development, and significant changes in land use, which can alter the epidemiology of infectious diseases. For instance, a study analyzing 31 provincial data from China between 2002 and 2018 found that while the increase in population due to urbanization does not aggravate the spread of infectious diseases, it is the urban education, employment opportunities, and improved public services that can help reduce the risk of disease transmission. However, the increasing density of buildings associated with land urbanization has been shown to elevate the risk of infectious disease spread, indicating a nuanced impact of urbanization on public health [27].

Moreover, urban areas often experience heightened temperatures and pollution levels, which can favor the proliferation of disease vectors, particularly mosquitoes. Urbanization facilitates the development of infrastructures conducive to mosquito breeding, thus increasing the risk of mosquito-borne infectious diseases (MBIDs). The alteration of mosquito life history traits due to urban environmental changes directly influences their ability to transmit diseases, highlighting urbanization as a significant public health concern [28].

The dynamics of urbanization also play a crucial role in the emergence and recurrence of infectious diseases in specific regions. For example, in rapidly urbanizing areas such as Djibouti City, changes in epidemiology due to urban migration, ecological shifts, and rising poverty have led to the emergence of diseases that were previously under control [25]. This illustrates that urban environments can serve as breeding grounds for infectious diseases, necessitating tailored public health responses.

Additionally, the interaction between urbanization and climate change further complicates the landscape of infectious disease transmission. Urban growth generates spatial heterogeneity that can modulate the effects of climate factors on disease dynamics, particularly in developing countries where socioeconomic disparities exacerbate vulnerability to infectious diseases [29].

Furthermore, urbanization is linked to the emergence of zoonotic diseases, as anthropogenic pressures create diverse wildlife-livestock-human interfaces that facilitate cross-species transmission of pathogens. Understanding these interfaces is critical for identifying interventions to mitigate disease emergence [30].

In summary, the impacts of emerging infectious diseases are significantly shaped by urbanization and population density, which alter ecological and social conditions conducive to disease transmission. Urbanization can enhance the risk of infectious diseases through increased vector habitats, socioeconomic inequalities, and changes in human behavior, necessitating comprehensive public health strategies to address these challenges effectively.

3.4 Human Behavior and Zoonotic Spillover ​

Emerging infectious diseases, particularly those of zoonotic origin, present significant public health risks and economic burdens globally. A critical factor in the emergence of these diseases is the interplay between human behavior and zoonotic spillover events. These spillover events occur when pathogens jump from animal hosts to humans, leading to potential outbreaks.

Human activities, including land-use changes, urbanization, and agricultural practices, significantly contribute to the increased frequency of zoonotic spillover. For instance, the World Health Organization has reported that approximately 60% of emerging infectious diseases are zoonoses originating from spillover events, highlighting the direct link between human encroachment on wildlife habitats and the emergence of infectious diseases (Saldaña et al., 2024) [31]. As human populations expand into wildlife habitats, the opportunities for interactions between humans and wildlife increase, which can facilitate the transmission of pathogens.

Furthermore, the dynamics of these spillover events are influenced by various factors, including the ecological and epidemiological characteristics of the pathogens involved. For example, viruses with high host plasticity, meaning they can infect a wide range of host species, are more likely to result in successful spillover and subsequent human-to-human transmission. This capability can amplify the spread of zoonotic diseases across geographic regions, as seen in the historical trends of high-consequence zoonotic viruses, which have demonstrated increasing frequency and severity of spillover events (Meadows et al., 2023) [32].

The complexity of these interactions necessitates a multifaceted approach to understanding and mitigating the risks associated with zoonotic spillover. The modeling of spillover dynamics, for instance, can provide insights into the intricate relationships between pathogens, wildlife, and human populations, thereby aiding in predicting potential outbreaks (Golchin et al., 2024) [33]. Additionally, the development of frameworks for rapid risk assessment can help identify key risk factors for human-wildlife transmission, thereby informing surveillance and risk mitigation strategies (McDevitt-Galles et al., 2025) [34].

In conclusion, the emergence of infectious diseases is intricately linked to human behavior, particularly through activities that disrupt natural ecosystems and facilitate zoonotic spillover. Addressing these challenges requires a concerted global effort to improve understanding, surveillance, and prevention strategies to mitigate the risks posed by emerging infectious diseases.

4 Health Impacts of Emerging Infectious Diseases ​

4.1 Burden on Health Systems ​

Emerging infectious diseases (EIDs) have significant health impacts that extend beyond immediate clinical consequences, placing a substantial burden on health systems, particularly in low- and middle-income countries (LMICs). The health needs of populations are evolving, as evidenced by the double burden of infectious and chronic diseases, which constitutes major causes of morbidity and mortality globally. In recent decades, the rise of EIDs, such as SARS, H1N1, Ebola, and COVID-19, has highlighted the vulnerabilities of health systems, especially in resource-poor settings [9].

The COVID-19 pandemic, in particular, has underscored deficiencies in existing global health systems and emergency management frameworks. It has revealed critical gaps in disease surveillance and response capabilities, leading to unfulfilled targets in health system resilience [2]. The burden of EIDs often exacerbates existing inequalities, with women and marginalized groups experiencing disproportionately negative effects on their sexual and reproductive health services. The disruptions caused by outbreaks can paralyze essential health services, which are crucial for addressing the needs of vulnerable populations [9].

Moreover, EIDs impact not only health but also political, economic, and social domains. They create challenges for public health authorities tasked with protecting and improving community health, promoting healthy practices, and conducting research on disease prevention [1]. The interplay between EIDs and health systems is complex, as outbreaks can lead to significant economic consequences, further straining health resources and exacerbating health inequities [2][9].

In summary, the emergence of infectious diseases presents multifaceted challenges that necessitate urgent and coordinated efforts to strengthen health systems. The focus should be on enhancing surveillance, improving emergency preparedness, and ensuring that health services remain accessible to all, particularly the most vulnerable populations [2][35]. Addressing these issues is crucial for mitigating the health impacts of EIDs and improving overall health outcomes in affected communities.

4.2 Morbidity and Mortality Rates ​

Emerging infectious diseases (EIDs) have profound impacts on public health, particularly concerning morbidity and mortality rates. The health challenges posed by these diseases are multifaceted, affecting both developed and developing nations. In the year 2000, infectious diseases were responsible for approximately 17 million deaths annually, accounting for about a third of all deaths worldwide[36]. This statistic underscores the critical role that infectious diseases play in global health and highlights the urgent need for effective surveillance and response strategies.

Over the past two decades, the emergence of various infectious diseases, including the severe acute respiratory syndrome virus (SARS), H1N1 pandemic influenza, Ebolavirus, and COVID-19, has led to significant increases in morbidity and mortality rates. These diseases have rapidly spread across the globe, revealing the interconnectedness of modern civilization and the vulnerabilities within health systems, particularly in Low-and Middle-income Countries (LMICs) with fragile infrastructures[9].

The rise in EIDs is attributed to several factors, including changes in human demographics and behavior, economic development, land use, and rapid international travel[3]. These factors contribute to the emergence and re-emergence of diseases, which can disrupt public health measures and overwhelm healthcare systems. The social and economic consequences of outbreaks are often dramatic, particularly in resource-poor settings where health services are already limited. Women and marginalized groups tend to be disproportionately affected, facing increased health risks and barriers to accessing care[9].

Moreover, the emergence of novel pathogens has led to increased morbidity among vulnerable populations, particularly immunocompromised individuals. As new fungal infections and other pathogens emerge, they impose a significant health burden, further complicating the management of existing health conditions[37]. The implications of these emerging diseases extend beyond immediate health concerns, threatening food security, wildlife conservation, and biodiversity, thus posing broader ecological risks[14].

In summary, emerging infectious diseases are a perpetual challenge, significantly impacting morbidity and mortality rates worldwide. The complexity of these health threats necessitates a coordinated global response, emphasizing the importance of international and interdisciplinary partnerships to enhance surveillance, improve health systems, and address the unique needs of affected populations[38].

4.3 Mental Health Consequences ​

Emerging infectious diseases (EIDs) significantly affect public health, extending their impact beyond physical health to encompass mental health and societal well-being. The consequences of these diseases are multifaceted, often resulting in profound mental health challenges for affected populations.

The psychological toll of emerging infectious diseases can be considerable. Stigma associated with these diseases frequently exacerbates mental health issues. For instance, in the context of the mpox outbreak, individuals from marginalized communities, such as gay, bisexual, and other men who have sex with men (GBMSM), reported feelings of stigma and shame linked to their diagnosis. This stigma was often intensified by media portrayals that drew on homophobic stereotypes, contributing to emotional distress and isolation among affected individuals [39].

Furthermore, individuals living with pre-existing conditions, such as HIV, appeared to cope better with the stigma surrounding mpox due to their prior experiences with illness-related discrimination. In contrast, younger GBMSM, who had less exposure to stigmatizing health experiences, found the diagnosis of mpox particularly traumatic, indicating a need for enhanced psychological support and resources [39].

The experience of illness itself can lead to significant mental health challenges. Those diagnosed with EIDs may face anxiety related to their health status, fears of transmission, and uncertainties about treatment outcomes. The emotional and psychological impact of living with an infectious disease is compounded by challenges in accessing timely and appropriate healthcare, particularly when healthcare professionals fail to recognize symptoms or provide adequate support [39].

Additionally, the emergence of infectious diseases often coincides with broader societal disruptions, such as rapid urbanization, economic instability, and increased international travel, which can further strain mental health resources. The interplay of these factors necessitates a comprehensive approach to public health that not only addresses the immediate health concerns posed by EIDs but also prioritizes mental health support [3].

In summary, the impacts of emerging infectious diseases extend deeply into mental health, necessitating targeted interventions that consider the psychological needs of affected populations. This includes addressing stigma, providing mental health resources, and ensuring that healthcare systems are equipped to support individuals dealing with the complex emotional ramifications of their diagnoses. As such, it is essential for public health policies to incorporate mental health strategies alongside infectious disease management to foster holistic community health outcomes [1][38].

5 Economic and Social Impacts ​

5.1 Economic Consequences of EIDs ​

Emerging infectious diseases (EIDs) have profound economic consequences that extend beyond immediate public health impacts. The economic ramifications are often intertwined with broader social and environmental factors, leading to complex and far-reaching effects.

EIDs can elicit significant economic shock waves that affect various sectors, primarily due to rapid and extensive international travel and trade. Such events can disrupt markets, lead to declines in productivity, and impose substantial costs on healthcare systems. Smith et al. (2019) highlight that the socioeconomic consequences of emerging and endemic infectious disease events are frequently underestimated in risk assessments. The indirect impacts on private sector organizations, which are often overlooked, can be substantial, as these entities play a critical role in providing information, resources, and partnerships necessary for public health responses to infectious disease threats[40].

The emergence of infectious diseases also threatens food security and wildlife conservation, with significant implications for biodiversity and ecological balance. Hatcher et al. (2012) discuss how EIDs are recognized as having considerable social, economic, and ecological costs, emphasizing the need for a comprehensive understanding of the processes underlying disease emergence, which includes factors such as environmental change and global transport. These factors facilitate the introduction and spread of novel pathogens, leading to economic disruptions in agriculture and wildlife sectors[14].

Furthermore, the relationship between economic crises and the risk of infectious disease outbreaks has been documented. Economic sanctions, for instance, can exacerbate health determinants and increase the risk of disease spread. Aloosh and Aloosh (2023) argue that economic sanctions induce crises that compromise health systems' capacities, potentially leading to outbreaks of infectious diseases[41].

Cohen (1998) elaborates on the broader societal changes that contribute to the emergence of EIDs, including demographic shifts, technological advancements, and changes in land use and economic development. These factors can create conditions conducive to the emergence and re-emergence of infectious diseases, resulting in significant economic burdens on healthcare systems and societal structures[3].

In summary, the economic consequences of emerging infectious diseases are multi-faceted, impacting public health systems, food security, and overall economic stability. Addressing these challenges requires a coordinated response that considers the complex interplay of ecological, social, and economic factors influencing disease emergence and spread.

5.2 Impact on Workforce and Productivity ​

Emerging infectious diseases (EIDs) significantly impact workforce and productivity across various sectors. A systematic review of 55 studies from 1984 to 2021, which included data from 46,813,038 participants globally, highlighted that outbreaks of diseases such as Coronavirus Disease 2019 (COVID-19), influenza, and tuberculosis lead to increased morbidity and mortality, which in turn escalate health costs. These direct health impacts subsequently generate indirect socioeconomic consequences, particularly affecting employment and workforce size[42].

The review identified several critical indirect impacts stemming from EIDs. Employment crises are prevalent, as increased illness among workers reduces the available labor force. This reduction not only hampers productivity but also leads to economic disruptions, such as demand shocks and supply chain interruptions. The increased costs associated with health measures, production, and service delivery further compound these issues, resulting in significant financial losses and declines in Gross Domestic Product (GDP) attributable to productivity losses from illnesses and governmental policy responses aimed at containing the spread of diseases[42].

Moreover, the economic implications of EIDs extend beyond immediate health costs. The COVID-19 pandemic exemplifies how infectious diseases can reshape economic landscapes, with long-term effects on labor supply and overall economic output. The integration of health capital—investments in health systems and policies—has been shown to mitigate some of the adverse effects on productivity by enhancing recovery rates and reducing the spread of disease. This suggests that effective public health policies can play a crucial role in sustaining workforce productivity during outbreaks[43].

In summary, emerging infectious diseases impose severe economic and social costs by disrupting workforce dynamics and productivity. These impacts are characterized by increased health-related costs, reduced labor availability, and broader economic instability, necessitating comprehensive public health strategies to enhance resilience against future outbreaks[42][43].

5.3 Social Disruption and Inequality ​

Emerging infectious diseases (EIDs) have profound economic and social impacts, particularly in terms of social disruption and inequality. The effects of these diseases extend beyond mere health concerns, influencing various aspects of society, including economic stability, social structures, and public health systems.

The rapid spread of EIDs, such as COVID-19, has underscored the vulnerabilities of populations, especially in low- and middle-income countries (LMICs) with fragile health systems. These nations often experience dramatic social and economic consequences when outbreaks occur. For instance, the disruptions caused by EIDs can paralyze normal services dedicated to Sexual and Reproductive Health (SRH), exacerbating gender inequalities and further disadvantaging women and girls, who are often left to bear the brunt of health system failures (Chattu & Yaya, 2020) [9].

Social inequalities significantly influence the distribution and impact of EIDs. Research has shown that these diseases tend to affect marginalized populations disproportionately, revealing the critical interplay between social determinants of health and disease emergence. Outbreaks of diseases like Ebola, AIDS, and tuberculosis illustrate how social inequalities shape not only the distribution of infectious diseases but also the outcomes for those affected. Thus, models of disease emergence must incorporate dynamic and systemic perspectives that consider local variations and broader social forces (Farmer, 1996) [44].

Moreover, the economic implications of EIDs are substantial. The socio-economic shocks resulting from these diseases can lead to widespread unemployment and economic instability, affecting not only public health but also sectors such as retail and services. This economic fallout can perpetuate cycles of poverty and inequality, making it increasingly difficult for vulnerable populations to access necessary healthcare and support systems (Ceylan et al., 2020) [45].

Additionally, the global nature of modern society, characterized by increased international travel and commerce, has heightened the risks associated with EIDs. The interconnectedness of populations means that outbreaks can rapidly transcend borders, complicating containment efforts and necessitating coordinated responses that are often hindered by existing inequalities in health infrastructure and resource allocation (Cohen, 1998) [3].

In conclusion, the impacts of emerging infectious diseases encompass significant social disruption and inequality. Addressing these challenges requires a comprehensive understanding of the socio-economic context in which EIDs emerge and spread, alongside a commitment to strengthening health systems and reducing inequalities that exacerbate their effects. Collaborative efforts across sectors and disciplines are essential to mitigate the multifaceted impacts of EIDs and promote equitable health outcomes for all populations.

6 Strategies for Mitigation and Preparedness ​

6.1 Surveillance and Early Detection ​

Emerging infectious diseases (EIDs) significantly affect not only the health of human and animal populations but also extend their impact to political, economic, social, and environmental domains, as well as inter-state relations. Understanding these multifaceted impacts is crucial for public health authorities in their roles of protecting and improving community health, promoting healthy practices, and conducting research on disease prevention and mitigation [1].

The emergence of novel infections is often linked to various human and ecological factors, such as population density, international travel and trade, climate change, and agricultural practices. Effective surveillance of these diseases is vital for the early identification of public health threats, enabling timely intervention [46]. Furthermore, emerging infectious diseases continue to impose unpredictable burdens on global health and the economy, highlighting the necessity of robust infectious disease surveillance and pandemic preparedness systems [47].

In response to the growing threat of EIDs, several strategies for mitigation and preparedness have been proposed. These strategies emphasize the importance of enhancing surveillance systems to detect and respond to infectious disease threats effectively. The Centers for Disease Control and Prevention (CDC) has developed a strategic plan that outlines specific objectives under four major goals: surveillance and response, applied research, infrastructure and training, and prevention and control [4]. This comprehensive approach aims to bolster the understanding of infectious diseases and improve their detection, control, and prevention [48].

A critical component of these strategies involves the implementation of modern surveillance systems. Improved surveillance can facilitate the prompt detection of new and resurgent infectious disease threats, which is essential for public health safety [49]. The integration of new technologies, such as web-based surveillance tools and epidemic intelligence methods, has been increasingly recognized as a means to enhance the accuracy and timeliness of outbreak detection [46].

Moreover, local and regional surveillance capacities are particularly important in low- and middle-income countries (LMICs), where many known drivers of EID emergence converge. Strengthening these capacities can help address existing inequalities in health systems and improve the ability to detect and contain EIDs [17]. This localized approach not only contributes to global health security but also aligns with broader development goals.

In summary, the impacts of emerging infectious diseases are extensive and complex, necessitating a multifaceted response that includes improved surveillance and early detection systems. The strategic implementation of these systems is crucial for mitigating the effects of EIDs and preparing for future outbreaks, ensuring that public health authorities can effectively protect communities and respond to emerging threats.

6.2 Public Health Interventions ​

Emerging infectious diseases (EIDs) pose significant threats to public health, impacting not only health systems but also extending to political, economic, social, and environmental domains. A deeper understanding of these impacts is crucial for public health authorities to effectively protect and improve community health, promote healthy practices, and engage in research aimed at disease prevention and mitigation [1].

The emergence and re-emergence of infectious diseases are influenced by various factors, including changes in human demographics and behavior, advancements in technology and industry, shifts in economic development and land use, and increasing international travel and commerce. These changes can lead to unpredictable consequences, as evidenced by the emergence of new diseases and the resurgence of previously controlled infections [3]. The public health landscape is particularly affected by rapid urbanization, population growth, and poverty, which contribute to the vulnerability of populations to infectious diseases [25].

To mitigate the impacts of EIDs, several strategies have been proposed. A strategic plan developed by the Centers for Disease Control and Prevention (CDC) emphasizes four main goals: enhancing surveillance and response capabilities, promoting applied research, strengthening public health infrastructure and training, and implementing effective prevention and control measures [4]. This comprehensive approach aims to bolster the capacity of public health systems to detect and respond to both known and unexpected disease threats.

Public health interventions must also focus on fostering international and interdisciplinary partnerships to build an appropriate infrastructure for disease detection and response [3]. Collaborative efforts among health departments, federal agencies, medical associations, and international organizations are essential for addressing the multifaceted challenges posed by emerging infectious diseases [4].

In addition to traditional public health measures, the One Health approach, which integrates human, animal, and environmental health considerations, is gaining traction as a means to address the complexities of emerging pathogens [50]. This approach underscores the necessity of interdisciplinary collaboration in combating infectious diseases, recognizing that human health is intricately linked to the health of animals and ecosystems.

The implementation of these strategies requires a long-term commitment and the engagement of various stakeholders, including healthcare providers, researchers, and public health professionals, to ensure a robust response to the evolving landscape of infectious diseases [51]. By learning from past experiences and adapting to emerging challenges, public health systems can enhance their preparedness and resilience against future outbreaks.

6.3 Role of Vaccination and Treatment ​

Emerging infectious diseases (EIDs) pose significant challenges to public health, influencing not only health outcomes but also extending their impact to political, economic, social, and environmental domains. The implications of EIDs are profound, as they can disrupt societal structures and strain healthcare systems. Understanding these impacts is essential for public health authorities tasked with protecting and improving community health, promoting healthy practices, and advancing research on disease prevention and mitigation strategies (Burgos & Ear, 2015) [1].

The emergence of various infectious viruses from wildlife or the re-emergence of known pathogens has raised serious threats to global health and economic stability. Notable examples include Ebola, Marburg, and various vector-borne diseases such as Zika and Chikungunya, alongside significant respiratory viruses like SARS and MERS. The COVID-19 pandemic has further underscored the urgent need for rapid intervention strategies, including vaccination, to mitigate morbidity and mortality associated with these diseases (Trovato et al., 2020) [52].

Addressing the impacts of EIDs necessitates a multifaceted approach, including enhanced surveillance, research, and public health infrastructure. Recent outbreaks highlight deficiencies in current surveillance systems and the need for improved data collection and reporting mechanisms. Lessons learned from past pandemics emphasize the importance of defining what constitutes a pandemic, understanding the nuances of clinical research, and developing effective triage protocols (Bloch et al., 2024) [53].

Vaccination plays a crucial role in mitigating the effects of EIDs. Historically, vaccination has proven to be one of the most effective tools for activating protective immune responses against pathogens, thereby reducing the incidence of disease and death. However, the emergence of new and re-emerging pathogens has necessitated innovative approaches to vaccine development. These approaches should leverage advanced technologies and methodologies to ensure rapid and effective vaccine deployment during outbreaks (Kennedy et al., 2014) [54].

Moreover, funding and global cooperation are critical for the development of vaccines against emerging infectious diseases. The Coalition for Epidemic Preparedness Innovations (CEPI) was established to address the challenges of funding and coordinating vaccine research and development, especially in light of unpredictable outbreaks (Wong & Qiu, 2018) [55].

In summary, the impacts of emerging infectious diseases are extensive, necessitating a comprehensive strategy that includes improved surveillance, innovative vaccination approaches, and international collaboration to enhance preparedness and response capabilities. By addressing these factors, public health systems can better manage the threats posed by EIDs and safeguard global health.

6.4 Importance of Global Collaboration ​

Emerging infectious diseases (EIDs) represent significant public health threats with profound impacts on population health, economic stability, and social development. The burden of these diseases is unpredictable and can lead to public health emergencies of international concern, as evidenced by outbreaks such as COVID-19, Ebola, and Zika. The implications of these diseases extend beyond immediate health effects, influencing global economies and social structures. For instance, the COVID-19 pandemic has highlighted the vulnerabilities within existing health systems and the necessity for robust emergency management frameworks [2].

To mitigate the impacts of EIDs, several strategies have been proposed. These include enhancing surveillance and response systems, conducting applied research, improving public health infrastructure, and fostering effective prevention and control measures. A systematic approach to these challenges is crucial, as past experiences have shown that gaps in preparedness can lead to catastrophic consequences. The need for integrated, sustainable, and cost-effective management strategies is increasingly recognized, especially in the context of globalization, which facilitates the rapid spread of infectious agents [56].

One of the most critical aspects of mitigating the risks associated with EIDs is the emphasis on global collaboration. Effective international cooperation is essential for the identification, control, and prevention of emerging diseases. The One Health approach, which integrates human, animal, and environmental health, has been advocated as a framework for fostering this collaboration. It emphasizes the need for countries to share biological materials and engage in equitable research partnerships, enhancing the capacity to detect potential pathogens before they escalate into serious threats [57].

The experience gained from recent outbreaks underscores the importance of a coordinated global response. For example, during the COVID-19 pandemic, the lack of multilateral cooperation in research, information sharing, and vaccine distribution significantly hampered global recovery efforts [58]. This situation illustrates that individual countries pursuing self-interests may lead to suboptimal outcomes; therefore, a collective approach is necessary to achieve better health outcomes for all [47].

Furthermore, addressing the challenges posed by EIDs requires a multi-disciplinary effort, engaging stakeholders across various sectors, including public health, research, and international organizations. The establishment of a Global Technical Council on Infectious Disease Threats has been proposed to enhance collaboration and coordination among different organizations, filling knowledge gaps in surveillance, research, and response [59]. Such initiatives can lead to improved preparedness and a more resilient global health system, capable of responding effectively to the dynamic landscape of infectious diseases.

In conclusion, the impacts of emerging infectious diseases are profound and multifaceted, necessitating comprehensive strategies for mitigation and preparedness. Central to these strategies is the importance of global collaboration, which is vital for enhancing surveillance, research, and response capabilities. By embracing a coordinated, One Health approach and fostering international partnerships, the global community can better prepare for and respond to the challenges posed by emerging infectious diseases.

7 Conclusion ​

The impacts of emerging infectious diseases (EIDs) are multifaceted, significantly affecting health systems, economies, and social structures globally. The review highlights key findings that underscore the urgent need for enhanced surveillance, robust health infrastructure, and international collaboration to mitigate the effects of EIDs. The historical context reveals a persistent pattern of disease emergence driven by environmental changes, globalization, urbanization, and human behavior. Future research should focus on understanding the complex interplay between these factors and their contributions to EID emergence, as well as developing innovative strategies for prevention and control. Additionally, addressing the social determinants of health and reducing inequalities will be crucial in managing the impacts of EIDs, particularly in low- and middle-income countries. The establishment of multidisciplinary and global partnerships is essential for building resilience against future outbreaks, ensuring that public health systems can effectively respond to the challenges posed by EIDs.

References ​

  • [1] S Burgos;S Ear. Emerging infectious diseases and public health policy: insights from Cambodia, Hong Kong and Indonesia.. Transboundary and emerging diseases(IF=3.0). 2015. PMID:23551938. DOI: 10.1111/tbed.12084.
  • [2] Xiao-Xi Zhang;Yin-Zi Jin;Yi-Han Lu;Lu-Lu Huang;Chuang-Xin Wu;Shan Lv;Zhuo Chen;Hao Xiang;Xiao-Nong Zhou. Infectious disease control: from health security strengthening to health systems improvement at global level.. Global health research and policy(IF=4.6). 2023. PMID:37670331. DOI: 10.1186/s41256-023-00319-w.
  • [3] M L Cohen. Resurgent and emergent disease in a changing world.. British medical bulletin(IF=5.2). 1998. PMID:10326281. DOI: 10.1093/oxfordjournals.bmb.a011707.
  • [4] . Preventing Emerging Infectious Diseases: A Strategy for the 21st Century. Overview of the Updated CDC plan.. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports(IF=60.1). 1998. PMID:9751113. DOI: .
  • [5] Leslie A Reperant;Albert D M E Osterhaus. AIDS, Avian flu, SARS, MERS, Ebola, Zika… what next?. Vaccine(IF=3.5). 2017. PMID:28633891. DOI: 10.1016/j.vaccine.2017.04.082.
  • [6] Yasir Waheed;Ranjit Sah;Khalid Muhammad. Recent Developments in Vaccines for Viral Diseases.. Vaccines(IF=3.4). 2023. PMID:36851076. DOI: 10.3390/vaccines11020198.
  • [7] Tracey Pérez Koehlmoos;Shahela Anwar;Alejandro Cravioto. Global health: chronic diseases and other emergent issues in global health.. Infectious disease clinics of North America(IF=4.1). 2011. PMID:21896363. DOI: 10.1016/j.idc.2011.05.008.
  • [8] Andreas G Tsantes;Rozeta Sokou;Vanessa Bellou;Dimitrios V Papadopoulos. Editorial for the Special Issue "Infectious Diseases: Emerging Diagnostic Methods, Updated Treatment Protocols and New Antimicrobial Agents".. Biology(IF=3.5). 2025. PMID:41007390. DOI: 10.3390/biology14091245.
  • [9] Vijay Kumar Chattu;Sanni Yaya. Emerging infectious diseases and outbreaks: implications for women's reproductive health and rights in resource-poor settings.. Reproductive health(IF=3.4). 2020. PMID:32238177. DOI: 10.1186/s12978-020-0899-y.
  • [10] Robert G Ridley. Research on infectious diseases requires better coordination.. Nature medicine(IF=50.0). 2004. PMID:15577932. DOI: 10.1038/nm1153.
  • [11] Seher Topluoglu;Aysegul Taylan-Ozkan;Emine Alp. Impact of wars and natural disasters on emerging and re-emerging infectious diseases.. Frontiers in public health(IF=3.4). 2023. PMID:37727613. DOI: 10.3389/fpubh.2023.1215929.
  • [12] S M Soto. Human migration and infectious diseases.. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases(IF=8.5). 2009. PMID:19220349. DOI: 10.1111/j.1469-0691.2008.02694.x.
  • [13] Kate E Jones;Nikkita G Patel;Marc A Levy;Adam Storeygard;Deborah Balk;John L Gittleman;Peter Daszak. Global trends in emerging infectious diseases.. Nature(IF=48.5). 2008. PMID:18288193. DOI: 10.1038/nature06536.
  • [14] Melanie J Hatcher;Jaimie T A Dick;Alison M Dunn. Disease emergence and invasions.. Functional ecology(IF=5.1). 2012. PMID:32313353. DOI: 10.1111/j.1365-2435.2012.02031.x.
  • [15] P Daszak;A A Cunningham;A D Hyatt. Emerging infectious diseases of wildlife--threats to biodiversity and human health.. Science (New York, N.Y.)(IF=45.8). 2000. PMID:10642539. DOI: 10.1126/science.287.5452.443.
  • [16] Ashwin Venkatesh;Ravi Patel;Simran Goyal;Timothy Rajaratnam;Anant Sharma;Parwez Hossain. Ocular manifestations of emerging viral diseases.. Eye (London, England)(IF=3.2). 2021. PMID:33514902. DOI: 10.1038/s41433-020-01376-y.
  • [17] Jo E B Halliday;Katie Hampson;Nick Hanley;Tiziana Lembo;Joanne P Sharp;Daniel T Haydon;Sarah Cleaveland. Driving improvements in emerging disease surveillance through locally relevant capacity strengthening.. Science (New York, N.Y.)(IF=45.8). 2017. PMID:28706036. DOI: 10.1126/science.aam8332.
  • [18] Alessandra Nava;Juliana Suieko Shimabukuro;Aleksei A Chmura;Sérgio Luiz Bessa Luz. The Impact of Global Environmental Changes on Infectious Disease Emergence with a Focus on Risks for Brazil.. ILAR journal(IF=3.1). 2017. PMID:29253158. DOI: 10.1093/ilar/ilx034.
  • [19] Michael B Mahon;Alexandra Sack;O Alejandro Aleuy;Carly Barbera;Ethan Brown;Heather Buelow;David J Civitello;Jeremy M Cohen;Luz A de Wit;Meghan Forstchen;Fletcher W Halliday;Patrick Heffernan;Sarah A Knutie;Alexis Korotasz;Joanna G Larson;Samantha L Rumschlag;Emily Selland;Alexander Shepack;Nitin Vincent;Jason R Rohr. A meta-analysis on global change drivers and the risk of infectious disease.. Nature(IF=48.5). 2024. PMID:38720068. DOI: 10.1038/s41586-024-07380-6.
  • [20] Priti Meena;Vivekanand Jha. Environmental Change, Changing Biodiversity, and Infections-Lessons for Kidney Health Community.. Kidney international reports(IF=5.7). 2023. PMID:37705916. DOI: 10.1016/j.ekir.2023.07.002.
  • [21] Simeona Jacinto. The impact of climate change on neuroinfectious diseases.. Current opinion in neurology(IF=4.4). 2025. PMID:40471846. DOI: 10.1097/WCO.0000000000001398.
  • [22] Ruby Kwak;Kanika Kamal;Alexandra Charrow;Saami Khalifian. Mass migration and climate change: Dermatologic manifestations.. International journal of women's dermatology(IF=3.1). 2021. PMID:33537399. DOI: 10.1016/j.ijwd.2020.07.014.
  • [23] Georgia Titcomb;Johnny Uelmen;Mark Janko;Charles Nunn. Infectious disease responses to human climate change adaptations.. Global change biology(IF=12.0). 2024. PMID:39171421. DOI: 10.1111/gcb.17433.
  • [24] Qiao Liu;Min Liu;Jue Liu. Climate-Sensitive Infectious Diseases under Global Climate Change.. Biomedical and environmental sciences : BES(IF=4.1). 2025. PMID:41088818. DOI: 10.3967/bes2025.077.
  • [25] G R Rodier;J P Parra;M Kamil;S O Chakib;S E Cope. Recurrence and emergence of infectious diseases in Djibouti city.. Bulletin of the World Health Organization(IF=5.7). 1995. PMID:8907768. DOI: .
  • [26] S M Ostroff;P Kozarsky. Emerging infectious diseases and travel medicine.. Infectious disease clinics of North America(IF=4.1). 1998. PMID:9494841. DOI: 10.1016/s0891-5520(05)70420-7.
  • [27] Dongsheng Yu;Xiaoping Li;Juanjuan Yu;Xunpeng Shi;Pei Liu;Pu Tian. Whether Urbanization Has Intensified the Spread of Infectious Diseases-Renewed Question by the COVID-19 Pandemic.. Frontiers in public health(IF=3.4). 2021. PMID:34900884. DOI: 10.3389/fpubh.2021.699710.
  • [28] Pénélope Duval;Pierre Antonelli;Christina Aschan-Leygonie;Claire Valiente Moro. Impact of Human Activities on Disease-Spreading Mosquitoes in Urban Areas.. Journal of urban health : bulletin of the New York Academy of Medicine(IF=4.1). 2023. PMID:37277669. DOI: 10.1007/s11524-023-00732-z.
  • [29] Mauricio Santos-Vega;Pamela P Martinez;Mercedes Pascual. Climate forcing and infectious disease transmission in urban landscapes: integrating demographic and socioeconomic heterogeneity.. Annals of the New York Academy of Sciences(IF=4.8). 2016. PMID:27681053. DOI: 10.1111/nyas.13229.
  • [30] James M Hassell;Michael Begon;Melissa J Ward;Eric M Fèvre. Urbanization and Disease Emergence: Dynamics at the Wildlife-Livestock-Human Interface.. Trends in ecology & evolution(IF=17.3). 2017. PMID:28029378. DOI: 10.1016/j.tree.2016.09.012.
  • [31] Fernando Saldaña;Nico Stollenwerk;Joseba Bidaurrazaga Van Dierdonck;Maíra Aguiar. Modeling spillover dynamics: understanding emerging pathogens of public health concern.. Scientific reports(IF=3.9). 2024. PMID:38684927. DOI: 10.1038/s41598-024-60661-y.
  • [32] Amanda Jean Meadows;Nicole Stephenson;Nita K Madhav;Ben Oppenheim. Historical trends demonstrate a pattern of increasingly frequent and severe spillover events of high-consequence zoonotic viruses.. BMJ global health(IF=6.1). 2023. PMID:37918874. DOI: 10.1136/bmjgh-2023-012026.
  • [33] Maryam Golchin;Moreno Di Marco;Paul F Horwood;Dean R Paini;Andrew J Hoskins;R I Hickson. Prediction of viral spillover risk based on the mass action principle.. One health (Amsterdam, Netherlands)(IF=4.5). 2024. PMID:38694617. DOI: 10.1016/j.onehlt.2024.100737.
  • [34] Travis McDevitt-Galles;Tricia L Fry;Katherine L D Richgels;Daniel A Grear. Rapid Risk Assessment Framework to Estimate Potential for Spillback at Human-Wildlife Interfaces.. Transboundary and emerging diseases(IF=3.0). 2025. PMID:40548252. DOI: 10.1155/tbed/4334954.
  • [35] Tim K Mackey;Bryan A Liang;Raphael Cuomo;Ryan Hafen;Kimberly C Brouwer;Daniel E Lee. Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment.. Clinical microbiology reviews(IF=19.3). 2014. PMID:25278579. DOI: 10.1128/CMR.00045-14.
  • [36] . Dermatological infectiology--Quo vadis? Symposium, Ruhr-University, September 29-30, 2000. Abstracts.. European journal of medical research(IF=3.4). 2000. PMID:11121370. DOI: .
  • [37] Célia Fortuna Rodrigues;Lucia Černáková. Advances in Fungal Infection Research: From Novel Diagnostics to Innovative Therapeutics.. Journal of fungi (Basel, Switzerland)(IF=4.0). 2025. PMID:41149883. DOI: 10.3390/jof11100693.
  • [38] David M Morens;Gregory K Folkers;Anthony S Fauci. Emerging infections: a perpetual challenge.. The Lancet. Infectious diseases(IF=31.0). 2008. PMID:18992407. DOI: 10.1016/S1473-3099(08)70256-1.
  • [39] T Charles Witzel;Andrew Ghobrial;Romain Palich;Hannah Charles;Alison J Rodger;Caroline Sabin;Alex Sparrowhawk;Erica R M Pool;Mateo Prochazka;Roberto Vivancos;Katy Sinka;Kate Folkard;Fiona M Burns;John Saunders. Experiences of mpox illness and case management among cis and trans gay, bisexual and other men who have sex with men in England: a qualitative study.. EClinicalMedicine(IF=10.0). 2024. PMID:38685928. DOI: 10.1016/j.eclinm.2024.102522.
  • [40] Kristine M Smith;Catherine C Machalaba;Richard Seifman;Yasha Feferholtz;William B Karesh. Infectious disease and economics: The case for considering multi-sectoral impacts.. One health (Amsterdam, Netherlands)(IF=4.5). 2019. PMID:30671528. DOI: 10.1016/j.onehlt.2018.100080.
  • [41] Mehdi Aloosh;Arash Aloosh. Economic sanctions and spread of infectious diseases.. Health policy (Amsterdam, Netherlands)(IF=3.4). 2023. PMID:37801882. DOI: 10.1016/j.healthpol.2023.104921.
  • [42] Ely Zarina Samsudin;Siti Munira Yasin;Nur-Hasanah Ruslan;Nik Nairan Abdullah;Ahmad Faiz Azhari Noor;Ahmad Fitri Abdullah Hair. Socioeconomic impacts of airborne and droplet-borne infectious diseases on industries: a systematic review.. BMC infectious diseases(IF=3.0). 2024. PMID:38229063. DOI: 10.1186/s12879-024-08993-y.
  • [43] Lijin Xiang;Mingli Tang;Zhichao Yin;Mengmeng Zheng;Shuang Lu. The COVID-19 Pandemic and Economic Growth: Theory and Simulation.. Frontiers in public health(IF=3.4). 2021. PMID:34604164. DOI: 10.3389/fpubh.2021.741525.
  • [44] P Farmer. Social inequalities and emerging infectious diseases.. Emerging infectious diseases(IF=6.6). 1996. PMID:8969243. DOI: 10.3201/eid0204.960402.
  • [45] Rahmiye Figen Ceylan;Burhan Ozkan;Esra Mulazimogullari. Historical evidence for economic effects of COVID-19.. The European journal of health economics : HEPAC : health economics in prevention and care(IF=3.0). 2020. PMID:32500243. DOI: 10.1007/s10198-020-01206-8.
  • [46] Eirini Christaki. New technologies in predicting, preventing and controlling emerging infectious diseases.. Virulence(IF=5.4). 2015. PMID:26068569. DOI: 10.1080/21505594.2015.1040975.
  • [47] Leslie A Reperant;John MacKenzie;Albert D M E Osterhaus. Periodic global One Health threats update.. One health (Amsterdam, Netherlands)(IF=4.5). 2016. PMID:28616469. DOI: 10.1016/j.onehlt.2015.11.001.
  • [48] . Addressing emerging infectious disease threats: a prevention strategy for the United States. Executive summary.. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports(IF=60.1). 1994. PMID:8164632. DOI: .
  • [49] R T Bryan;R W Pinner;R L Berkelman. Emerging infectious diseases in the United States, Improved surveillance, a requisite for prevention.. Annals of the New York Academy of Sciences(IF=4.8). 1994. PMID:7840468. DOI: 10.1111/j.1749-6632.1994.tb19892.x.
  • [50] Maha A Elbadry;Mary M Merrill;Meng-Meng Ma;Mai-Juan Ma;Jia-Hai Lu;Wu-Chun Cao;Gregory C Gray. China's great wall, Israel's Bar Lev Line, and passive infectious disease surveillance.. Military Medical Research(IF=22.9). 2014. PMID:25722872. DOI: 10.1186/2054-9369-1-15.
  • [51] D Satcher. Emerging infections: getting ahead of the curve.. Emerging infectious diseases(IF=6.6). 1995. PMID:8903147. DOI: 10.3201/eid0101.950101.
  • [52] Maria Trovato;Rossella Sartorius;Luciana D'Apice;Roberta Manco;Piergiuseppe De Berardinis. Viral Emerging Diseases: Challenges in Developing Vaccination Strategies.. Frontiers in immunology(IF=5.9). 2020. PMID:33013898. DOI: 10.3389/fimmu.2020.02130.
  • [53] Evan M Bloch;David J Sullivan;Arturo Casadevall;Shmuel Shoham;Aaron A R Tobian;Kelly Gebo. Applying lessons of COVID-19 and other emerging infectious diseases to future outbreaks.. mBio(IF=4.7). 2024. PMID:38780294. DOI: 10.1128/mbio.01109-24.
  • [54] Richard B Kennedy;Inna G Ovsyannikova;Nathaniel D Lambert;Iana H Haralambieva;Gregory A Poland. The personal touch: strategies toward personalized vaccines and predicting immune responses to them.. Expert review of vaccines(IF=4.8). 2014. PMID:24702429. DOI: 10.1586/14760584.2014.905744.
  • [55] Gary Wong;Xiangguo Qiu. Funding vaccines for emerging infectious diseases.. Human vaccines & immunotherapeutics(IF=3.5). 2018. PMID:29194012. DOI: 10.1080/21645515.2017.1412024.
  • [56] D P Fidler. Globalization, international law, and emerging infectious diseases.. Emerging infectious diseases(IF=6.6). 1996. PMID:8903206. DOI: 10.3201/eid0202.960201.
  • [57] Brian McCloskey;Osman Dar;Alimuddin Zumla;David L Heymann. Emerging infectious diseases and pandemic potential: status quo and reducing risk of global spread.. The Lancet. Infectious diseases(IF=31.0). 2014. PMID:25189351. DOI: .
  • [58] Mark Jit;Aparna Ananthakrishnan;Martin McKee;Olivier J Wouters;Philippe Beutels;Yot Teerawattananon. Multi-country collaboration in responding to global infectious disease threats: lessons for Europe from the COVID-19 pandemic.. The Lancet regional health. Europe(IF=13.0). 2021. PMID:34642675. DOI: 10.1016/j.lanepe.2021.100221.
  • [59] David E Bloom;Daniel Cadarette. Infectious Disease Threats in the Twenty-First Century: Strengthening the Global Response.. Frontiers in immunology(IF=5.9). 2019. PMID:30984169. DOI: 10.3389/fimmu.2019.00549.

MaltSci Intelligent Research Services ​

Search for more papers on MaltSci.com ​

Emerging Infectious Diseases · Public Health · Economic Impact · Social Inequality · Surveillance and Preparedness

© 2025 MaltSci